Sclerosis News and Research

RSS

Spinal Muscular Atrophy Foundation and BG Medicine collaborate

The Spinal Muscular Atrophy Foundation and BG Medicine have announced a collaboration to discover plasma biomarkers of drug efficacy for spinal muscular atrophy (SMA), the leading genetic cause of mortality in infants and toddlers.

18 Sep 2007

Immune system police recognize good and bad guys in the body

Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.

17 Sep 2007

It's back to the dark ages...hookworms to treat asthma!

Modern medicine may have stopped short of blood-letting, leeches and purges but parasitic worms could be making a come-back!

17 Sep 2007

Chronic fatigue syndrome linked to common stomach virus

A new study has provided some clues to the cause of the mystery illness called chronic fatigue syndrome (CFS).

17 Sep 2007

New insight into the mechanisms of Lou Gehrig's disease

There is no known cure for amyotrophic lateral sclerosis (ALS), often known as Lou Gehrig disease and motor neuron disease.

13 Sep 2007

Proteins Nox1 and Nox2 play important role in amyotrophic lateral sclerosis

University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

13 Sep 2007

New understanding of immune infertility

Most of us have never heard of immune infertility, yet it prevents many prospective parents from conceiving. Immune infertility is one of 80 autoimmune disorders, a group that includes better-known diseases like Multiple Sclerosis and Type 1 Diabetes.

13 Sep 2007

Disease activity increases after multiple sclerosis patients stop natalizumab

People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity, according to a study published September 12, 2007, in the online edition of Neurology, the medical journal of the American Academy of Neurology.

13 Sep 2007

Embryonic stem cell strategy advanced with UCSF finding

UCSF scientists are reporting what they say is a significant improvement in the technique for genetically reprogramming mouse cells to their embryonic state, a process that transforms the cells, in essence, into embryonic stem cells.

12 Sep 2007

Link found between a lack of vitamin D and pre-eclampsia

Researchers in the United States have found an association between vitamin D levels in pregnant women and the risk of pre-eclampsia; they say women who have a vitamin D deficiency early in their pregnancy are at risk from pre-eclampsia.

9 Sep 2007

Researchers develop a long-acting growth hormone for use in human therapy

The new discovery could mean that children and adults with growth hormone disorders will not have to have injections as often, reducing the need for daily treatments.

5 Sep 2007

Nanotechnology helps identify molecular signature common to Lou Gehrig's disease

A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.

5 Sep 2007

Study identifies osteopontin as a key player in the body's immune response to chronic stress

Osteopontin (OPN), a protein molecule involved in many different cellular processes, plays a significant role in immune deficiency and organ atrophy following chronic physiological stress, resulting in increased susceptibility to illness.

4 Sep 2007

Mice stressed in simulated weightlessness show organ atrophy

A ground-based, experimental model used to simulate astronaut weightlessness in space has provided Rutgers scientists an opportunity to study the effects of stress on immune organs.

4 Sep 2007

Fingolimod shows promise in 2 lethal leukemias

A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia.

29 Aug 2007

New form of estrogen shows potential as multiple sclerosis drug

UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus.

28 Aug 2007

MRI helps find new abnormality related to disease progression and disability in patients with multiple sclerosis

Using magnetic resonance (MR) images of the brain, researchers have identified a new abnormality related to disease progression and disability in patients with multiple sclerosis (MS), according to a study published in the August issue of Radiology.

28 Aug 2007

Potential new leukemia drug

In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).

24 Aug 2007

Cannabis for allergic contact dermatitis

Administering a substance found in the cannabis plant can help the body's natural protective system alleviate an allergic skin disease (allergic contact dermatitis), an international group of researchers from Germany, Israel, Italy, Switzerland and the U.S. has found.

17 Aug 2007

MS patients given hope with new vaccine treatment

Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.

14 Aug 2007